2
Participants
Start Date
May 19, 2021
Primary Completion Date
September 17, 2021
Study Completion Date
September 28, 2022
Ridinilazole
Ridinilazole 200mg dosed BID for 10 days.
Vancomycin
Vancomycin 125mg dosed QID for 10 days.
Icahn School of Medicine at Mount Sinai, New York
DiGiovanna Institute for Medical Education and Research, New York
Stony Brook University Medical Center, Stony Brook
Children's Center for Digestive Health, Atlanta
HMD Research, Orlando
Continental Clinical Research, Miami
Dynamic Medical Research LLC, Miami
D&H National Research Centers, Miami
University Hospitals Cleveland Medical Center - Rainbow Babies and Children's Hospital, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Indiana University Health - Riley Hospital for Children, Indianapolis
Children's Hospital of Michigan, Detroit
Ann and Robert H Lurie Children's Hospital of Chicago, Chicago
University of Chicago - Comer Children's Hospital, Chicago
Snake River Research, Idaho Falls
University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles
Children's Hospital Orange County, Orange
Boston Children's Hospital, Boston
Lead Sponsor
Department of Health and Human Services
FED
Summit Therapeutics
INDUSTRY